MARKET

RNAZ

RNAZ

Transcode Therapeutics Inc
NASDAQ
5.59
-0.02
-0.27%
Opening 10:13 06/08 EDT
OPEN
5.43
PREV CLOSE
5.60
HIGH
5.59
LOW
5.12
VOLUME
8.32K
TURNOVER
--
52 WEEK HIGH
20.99
52 WEEK LOW
3.820
MARKET CAP
5.31M
P/E (TTM)
-0.1146
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RNAZ last week (0601-0605)?
Weekly Report · 5h ago
TransCode Therapeutics to Host R&D Webcast on June 18, 2026
Barchart · 7h ago
Transcode reports results from Phase 1a dose escalation trial with TTX-MC138
TipRanks · 5d ago
Pre-Market Movers: PMI, CNTB, RNAZ Chart The Course
NASDAQ · 5d ago
TransCode Therapeutics Advances TTX-MC138 After Positive Phase 1a
TipRanks · 5d ago
TransCode Therapeutics reports Phase 1a trial of TTX-MC138 meets safety endpoint in metastatic cancer
PUBT · 5d ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 5d ago
TRANSCODE THERAPEUTICS SUCCESSFULLY COMPLETES PHASE 1A CLINICAL TRIAL, REPORTS SAFETY AND STABILIZATION DATA FOR TTX-MC138 IN METASTATIC CANCER
Reuters · 5d ago
More
About RNAZ
TransCode Therapeutics, Inc. is a clinical-stage oncology company focused on treating metastatic disease. It is defeating cancer through the intelligent design and effective delivery of RNA therapeutics based on its proprietary TTX nanoparticle platform. Its lead candidate, TTX-MC138, targets metastatic tumors overexpressing microRNA-10b, a biomarker of metastasis. The Company is also developing a portfolio of RNA therapeutic candidates to overcome delivery challenges and unlock access to novel genetic targets. Its preclinical programs include TTX-siPDL1 (siRNA modulator of PD-L1), TTX-RIGA (RNA agonist of RIG-I for innate immunity activation), and TTX-siMYC (siRNA inhibitor of c-MYC). Additionally, R&D efforts are exploring the combination of TTX-MC138 and seviprotimut-L technologies to enhance therapeutic impact.

Webull offers Transcode Therapeutics Inc stock information, including NASDAQ: RNAZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RNAZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RNAZ stock methods without spending real money on the virtual paper trading platform.